Clinical Ethics > Volume 4, Number 3 > Pp. 119-124

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Fovargue, S. Articles by Ost, S. Social Bookmarking                      What's this?

Public Policy & Law

A plea for precaution with public health: the xenotransplantation example

Sara Fovargue    and Suzanne Ost 

Law School, Lancaster University, Lancaster LA1 4YN, UK

E-mail: s.fovargue{at}lancaster.ac.uk

In this paper we argue that while individual private interests such as autonomy and the need for a medical procedure or treatment are important in the provision and delivery of health care and the utilization of biotechnologies, these concepts need to be balanced with other interests such that in certain situations they do not take priority. We use as an example a particular developing biotechnology, xenotransplantation, to suggest that interest in the health of the public is such that this biotechnology should not be permitted to move to the clinical trial stage because of the particular risk of harm it poses to the potential xeno-recipient, their close contacts and the wider population. This is despite the interest of those in need of a transplant in allowing such clinical trials to proceed. We derive support for our position from John Stuart Mill's harm principle.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?